ADVERTISEMENT
b ef a a d b c a

China’s new seaweed-based Alzheimer’s therapy raises hopes—and questions about safety, effectiveness

Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed, potentially shaking up the field ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists